Viet
ELITE MEMBER
- Joined
- Jun 18, 2012
- Messages
- 29,949
- Reaction score
- 0
- Country
- Location
December 21, 2020 (Mainichi Japan)
The Fujifilm Holdings Corp. headquarters building is seen in Tokyo. (Mainnichi)
HO CHI MINH CITY (Kyodo) -- Japanese precision chemistry firm Fujifilm Corp. will make novel coronavirus antigen testing kits in Vietnam for global markets by expanding its local production facilities.
Fujifilm will invest an undisclosed amount in Fujifilm Yuwa Medical Products Vietnam Co., a joint venture producing diagnostic agents, from next year to the fiscal year starting in April 2022 to build a monthly production capacity of 2 million testing kits, an official of the Tokyo-based company said Friday. A date for the start of production there has yet to be decided.
With its own technology used in the photo printing process, the kits can quickly and easily detect the novel coronavirus antigens. In Japan, Fujifilm plans to produce the kits at its plant in Kanagawa Prefecture, west of Tokyo, as it has applied for manufacturing and marketing approval to the state's examining authority, the company said in a statement issued Thursday.
Fujifilm Yuwa Medical Products was established in May in Binh Duong Province, southern Vietnam, with Fujifilm owning 51 percent and Yuwa Co., a molding maker based in Nagano Prefecture, 49 percent and started producing diagnostic drugs in November, according to the statement.
In antigen tests, doctors insert swabs into a patient's nostril and put nasal discharge on a testing kit plate to get the result on site. Despite its lower accuracy than the currently dominant polymerase chain reaction, or PCR, tests, the quick and easy method is expected to be used in airports and event venues as well as hospitals, with demand likely to grow.
mainichi.jp
HO CHI MINH CITY (Kyodo) -- Japanese precision chemistry firm Fujifilm Corp. will make novel coronavirus antigen testing kits in Vietnam for global markets by expanding its local production facilities.
Fujifilm will invest an undisclosed amount in Fujifilm Yuwa Medical Products Vietnam Co., a joint venture producing diagnostic agents, from next year to the fiscal year starting in April 2022 to build a monthly production capacity of 2 million testing kits, an official of the Tokyo-based company said Friday. A date for the start of production there has yet to be decided.
With its own technology used in the photo printing process, the kits can quickly and easily detect the novel coronavirus antigens. In Japan, Fujifilm plans to produce the kits at its plant in Kanagawa Prefecture, west of Tokyo, as it has applied for manufacturing and marketing approval to the state's examining authority, the company said in a statement issued Thursday.
Fujifilm Yuwa Medical Products was established in May in Binh Duong Province, southern Vietnam, with Fujifilm owning 51 percent and Yuwa Co., a molding maker based in Nagano Prefecture, 49 percent and started producing diagnostic drugs in November, according to the statement.
In antigen tests, doctors insert swabs into a patient's nostril and put nasal discharge on a testing kit plate to get the result on site. Despite its lower accuracy than the currently dominant polymerase chain reaction, or PCR, tests, the quick and easy method is expected to be used in airports and event venues as well as hospitals, with demand likely to grow.
Japan's Fujifilm to make coronavirus antigen testing kits in Vietnam - The Mainichi
HO CHI MINH CITY (Kyodo) -- Japanese precision chemistry firm Fujifilm Corp. will make novel coronavirus antigen testing kits in Vietnam for global ma
